February 22, 2018 / 10:57 PM / 6 months ago

BRIEF-Mayne Pharma Group Posts H1 Loss Attributable Of $174.2 Mln

Feb 23 (Reuters) - Mayne Pharma Group Ltd:

* ‍HY REVENUE FROM ORDINARY ACTIVITIES $243.3 MILLION VERSUS $294.8 MILLION

* ‍HY LOSS FROM ORDINARY ACTIVITIES ATTRIBUTABLE $174.2 MILLION VERSUS PROFIT OF $72.7 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below